WASHINGTON, March 15, 2013 /PRNewswire-USNewswire/ -- The independent drugstore lobby is again seeking special antitrust exemptions (HR 1188) that would empower independent drugstores to charge consumers, employers, unions, and government agencies higher prescription drug prices, the Pharmaceutical Care Management Association (PCMA) said today.
A recent Government Accountability Office (GAO) report found that nearly 80 percent of independent drugstores already hire powerful Pharmacy Service Administrative Organizations (PSAOs) to negotiate their contract terms, negating any need for sweeping changes to antitrust laws.
"Prescription drug prices for employers, unions, government agencies, and consumers will skyrocket if competing independent drugstores are given a license to collude," said PCMA President and CEO Mark Merritt . "Prospects for this bill won't be helped by the GAO's recent finding that independent drugstores already hire large and powerful PSAOs to collectively bargain for higher payments."
According to the GAO report:
CBO: Collective Bargaining Would Increase Costs to the Federal Government
FTC: Collective Bargaining a "Costly Step Backward"
CRA Study: H.R. 1946 Would Increase Costs by Up to $15.6 billion
PCMA represents the nation's pharmacy benefit managers (PBMs), which improve affordability and quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 215 million Americans.
|SOURCE Pharmaceutical Care Management Association|
Copyright©2012 PR Newswire.
All rights reserved